David BenrimohChief Science Officer at Aifred Health
Psychiatry Residency Program and Chief Science Officer of Aifred Health, a Montreal based digital health startup. Aifred uses AI to improve treatment selection, starting with depression. David completed medical school at McGill. He then completed an MSc. Neuroscience at University College London with Karl Friston where he focused on computational models of hallucinations. He has published over 20 peer-reviewed papers on the topics of medical education, computational psychiatry, and applications of AI to medicine. He is currently team lead for Aifred's entry into the IBM Watson AI XPRIZE, where Aifred is currently a third round competitor.